Catalyst Pharmaceuticals Expands Commercial Leadership Team

Augments Medical Affairs Team with 3 Additional Medical Science Liaisons CORAL GABLES, Fla., Aug. 06, 2018 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing...

Patients and Biopharma: Trusted Partners in Fighting Rare Diseases

Significant advances have been made in fighting rare diseases over the past decades. In the 10 years prior to the passage of the Orphan Drug Act in 1983, fewer than 10 drugs for rare diseases were approved by the U.S. FDA. Since then, an estimated 400 rare-disease...